AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bernard-Gallon, D
Cravello, L
Vissac, C
Bignon, YJ
Citation: D. Bernard-gallon et al., Characterization of anti-BRCA2 antibodies in cell lines by Western blot analysis, ONCOL REP, 8(6), 2001, pp. 1363-1366
Authors:
Aunoble, B
Bernard-Gallon, D
Bignon, YJ
Citation: B. Aunoble et al., Regulation of BRCA1 and BRCA2 transcript in response to cisplatin, adriamycin, taxol and ionising radiation is correlated to p53 functional status inovarian cancer cell lines, ONCOL REP, 8(3), 2001, pp. 663-668
Authors:
Vissac, C
Antoine-Vincent, D
Maurizis, JC
Bignon, YJ
Bernard-Gallon, D
Citation: C. Vissac et al., Determination of BRCA2 oncosuppressor protein expression in human mammary cells by affinity perfusion high-performance chromatography, J BIOCH BIO, 49(1-3), 2001, pp. 657-663
Authors:
Bernard-Gallon, D
De Latour, MP
Rio, P
Favy, D
Hizel, C
Vissac, C
Bignon, YJ
Citation: D. Bernard-gallon et al., BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2, INT J CANC, 86(4), 2000, pp. 453-456
Authors:
Favy, DA
Lafarge, S
Rio, P
Vissac, C
Bignon, YJ
Bernard-Gallon, D
Citation: Da. Favy et al., Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines, BIOC BIOP R, 274(1), 2000, pp. 73-78
Authors:
Gosse-Brun, S
Sauvaigo, S
Daver, A
Page, M
Lortholary, A
Larra, F
Bignon, YJ
Bernard-Gallon, D
Citation: S. Gosse-brun et al., Specific H-ras minisatellite alleles in breast cancer susceptibility, ANTICANC R, 19(6B), 1999, pp. 5191-5196
Authors:
Presneau, N
Laplace-Marieze, V
Sylvain, V
Lortholary, A
Hardouin, A
Bernard-Gallon, D
Bignon, YJ
Citation: N. Presneau et al., Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast ovarian cancer families: possible implication of a mobile element, B CANCER, 86(4), 1999, pp. 385-390
Risultati:
1-7
|